Latest Views & News

Scancell – Vulpes Life Science Fund dumping: a 16.9% overhang?

By Nigel Somerville, the Deputy Sheriff of AIM | Tuesday 28 April 2020

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Having previously bravely (or perhaps stupidly) held on to my bullish beliefs in AIM-listed Scancell (SCLP), I finally threw in the towel last week after what appeared to be an attempted ramp by jumping on the Covid-19 bandwagon. I said sell – and it appears it was not just me looking to get out...

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was